B683 (Rabeprazole Sodium Delayed-Release 20 mg)
Pill with imprint B683 is Yellow, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Breckenridge Pharmaceutical, Inc..
Rabeprazole is used in the treatment of barrett's esophagus; erosive esophagitis; duodenal ulcer; duodenal ulcer prophylaxis; gerd and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for B683
- 20 mg
- 8.00 mm
- Prescription only
- Drug Class
- Proton pump inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Breckenridge Pharmaceutical, Inc.
- National Drug Code (NDC)
- Inactive Ingredients
diacetylated monoglycerides, hypromellose phthalate (31% phthalate, 40 cst), magnesium oxide, magnesium stearate, mannitol, magnesium silicate, titanium dioxide, ferric oxide yellow, ammonia, ferrosoferric oxide, propylene glycol, shellac
Note: Inactive ingredients may vary.
More about rabeprazole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 69 Reviews
- Drug class: proton pump inhibitors
- FDA Alerts (3)
- Rabeprazole Delayed-Release Tablets
- Rabeprazole Sprinkle Capsules
- Rabeprazole (Advanced Reading)